]Pharmaceutical Innovation Trends: What’s New Now
“`html Bexicaserin Shows Promise in Long-Term Treatment of Severe epilepsy Bexicaserin Shows Promise in Long-Term treatment of Severe Epilepsy Published: 2026/01/15 20:02:40 New long-term data presented at the American Epilepsy Society (AES) Congress in December 2025 indicates that bexicaserin (LP352), an investigational drug developed by Lundbeck, continues to demonstrate efficacy in reducing seizure frequency in … Read more